November 23, 2014 9:45 AM ET

Biotechnology

Company Overview of Adnexus Therapeutics, Inc.

Company Overview

Adnexus Therapeutics, Inc. discovers, develops, and distributes therapeutic class of biologics in the United States. The company’s product candidates include Angiocept/CT-322, an anti-angiogenesis agent for treating cancer that blocks the VEGFR-2 pathway; and other Adnectin therapies for the treatment of oncology, immunology, and cardiovascular diseases. Adnexus Therapeutics, Inc. was formerly known as Compound Therapeutics, Inc. and changed its name to Adnexus Therapeutics, Inc. in June 2006. The company was founded in 2002 and is headquartered in Waltham, Massachusetts. As of October 19, 2007, Adnexus Therapeutics, Inc. operates as a subsidiary of Bristol-Myers Squibb Company.

100 Beaver Street

Waltham, MA 02453

United States

Founded in 2002

58 Employees

Phone:

781-891-3745

Fax:

781-891-3796

Key Executives for Adnexus Therapeutics, Inc.

Co-founder
Age: 51
Associate Vice President of Oncology Program Management
Associate Vice President of Protein Design
Age: 57
Vice President of Early Candidate Assessment
Age: 53
Vice President of Manufacturing and Process Development
Age: 58
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
VitaCyte, LLC United States
Phyllom LLC United States
Prion Solutions, Inc. United States
AmKor Pharma, Inc. United States
Amarantus MA, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Adnexus Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.